Newsmakers

CytoDyn (OTC: CYDY) Provides Update on Dose Escalating Trial with Leronlimab for HIV Monotherapy for a Potential Pivotal Trial

VANCOUVER, Washington, Aug. 14, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today an […]

Newsmakers

NexTech AR (OTC: NEXCF) Signs eCommerce Deal with Cannabis Air Purification Company Alpine Innovative Research Inc.

NEW YORK and TORONTO, Aug. 13, 2019  — NexTech AR Solutions (the “Company” or “NexTech”) (OTCQB:NEXCF) (CSE:NTAR) (FSE:N29) is pleased to announce that it has entered into an agreement with Alpine Innovative Research Inc., a leading […]

Healthcare

CytoDyn (OTC: CYDY) Files a Phase 2 Protocol with the FDA for Leronlimab (PRO 140) and Regorafenib as a Combination Therapy for Metastatic Colorectal Cancer

VANCOUVER, Washington, Aug. 08, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the […]

Healthcare

Patient Treated with Leronlimab (PRO 140) for Metastatic Triple-Negative Breast Cancer under Emergency IND, Launching CytoDyn (OTC: CYDY) into Oncology

VANCOUVER, Washington, Aug. 06, 2019 – CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the […]

Newsmakers

Phunware (NASDAQ: PHUN) Partners with L&T Technology Services to Launch Phunware-Enabled Corporate Campus for Fortune 50 Company

LTTS to Implement Phunware’s Multiscreen-as-a-Service (MaaS) Platform to Build Corporate Campus of the Future Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, […]

Newsmakers

World’s Largest Astrological Site Astrology Zone® Partners with Phunware (NASDAQ: PHUN)

Susan Miller’s Astrology Zone® to Roll Out Access to Phunware’s Blockchain-enabled Data Exchange and Mobile Loyalty Ecosystem for Millions of Readers Phunware, Inc. (NASDAQ: PHUN), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, […]

Healthcare

CytoDyn (OTC: CYDY) Executes Exclusive Worldwide Licensing Agreement with IncellDX for PA-14 and PRO 140 for Diagnostic Testing Purposes

Agreement represents a revenue opportunity as a diagnostic test for receptor occupancy and the existence of CCR5 on cancer tissue and in HIV VANCOUVER, Washington, Jul 26, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the […]

Healthcare

CytoDyn (OTC: CYDY) Finalizes Development of Receptor Occupancy Test to Guide Pivotal Monotherapy Discussions With the FDA

VANCOUVER, Washington, Jul 25, 2019– – FDA face-to-face meeting granted to discuss pivotal monotherapy trial – Conference call for investors and media on Tuesday, July 30, 2019 at 4:00 p.m. ET with introduction to Dr. […]

Newsmakers

Phunware (NASDQ: PHUN) to Exhibit at the 2019 American Hospital Association Leadership Summit

Company to Demonstrate Frost & Sullivan “Company of the Year” Award-Winning Multiscreen-as-a-Service (MaaS) Platform for Healthcare Patient Experiences Phunware, Inc. (NASDQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, […]